Page last updated: 2024-09-04

torcetrapib and berberine

torcetrapib has been researched along with berberine in 1 studies

Compound Research Comparison

Studies
(torcetrapib)
Trials
(torcetrapib)
Recent Studies (post-2010)
(torcetrapib)
Studies
(berberine)
Trials
(berberine)
Recent Studies (post-2010) (berberine)
27328834,1061022,791

Protein Interaction Comparison

ProteinTaxonomytorcetrapib (IC50)berberine (IC50)
AcetylcholinesteraseElectrophorus electricus (electric eel)0.7827
Lysine-specific histone demethylase 1AHomo sapiens (human)6.97
CholinesteraseHomo sapiens (human)1.09
AcetylcholinesteraseHomo sapiens (human)0.4
Aldo-keto reductase family 1 member C3Homo sapiens (human)4.99
Aldo-keto reductase family 1 member C2 Homo sapiens (human)6.71
CholinesteraseEquus caballus (horse)9.4
Cytochrome P450 1B1Homo sapiens (human)0.9747

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Briand, F; Muzotte, E; Sulpice, T; Thieblemont, Q1

Other Studies

1 other study(ies) available for torcetrapib and berberine

ArticleYear
Upregulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamsters.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:1

    Topics: Animals; Berberine; Biological Transport; Cholesterol; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cholesterol, LDL; Cricetinae; Disease Models, Animal; Down-Regulation; Drug Therapy, Combination; Dyslipidemias; Feces; Hypolipidemic Agents; Kinetics; Lipoproteins, LDL; Liver; Liver X Receptors; Macrophages; Male; Mesocricetus; Orphan Nuclear Receptors; Quinolines; Up-Regulation

2013